¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ COVID-19 Ä¡·áÁ¦°³¹ß ±Û·Î¹ú Àӻ󿬱¸ ÇÁ·ÎÁ§Æ®ÇöȲ
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 


 

COVID-19 Ä¡·áÁ¦°³¹ß ±Û·Î¹ú Àӻ󿬱¸ ÇÁ·ÎÁ§Æ®ÇöȲ

 

½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(Äڷγª19) Ä¡·áÁ¦ °³¹ßÀ» À§ÇØ Àü¼¼°è°¡ ³ë·ÂÇÏ°í ÀÖ´Â °¡¿îµ¥, ÇöÀç Äڷγª 19 Ä¡·áÁ¦ °³¹ß°ú °ü·Ã ±¹Á¦ÀûÀ¸·Î Àӻ󿬱¸°¡ 335,815°ÇÀÌ ÁøÇà Áß¿¡ ÀÖ´Ù(2020³â 4¿ù 13ÀÏÀÚ µî·ÏÇöȲ). ¹Ì±¹ ±¹¸³º¸°Ç¿ø NIH ClinicalTrials.gov¿¡ µî·ÏµÇ¾î ÁøÇàÇÏ°í ÀÖ´Â COVID-19 °ü·Ã Àӻ󿬱¸´Â 300¿©°Ç ÀÌ»óÀÌ ÁøÇà Áß¿¡ ÀÖÀ¸¸ç, ¼¼°èº¸°Ç±â±¸(WHO)±¹Á¦Àӻ󿬱¸µî·Ï Ç÷§Æû(World Health Organization's International Clinical Trials Registry Platform, WHO ICTRP)¿¡¼­´Â 590°ÇÀÇ ÇÁ·ÎÁ§Æ®°¡ ÇöÀç Àӻ󿬱¸ Áß¿¡ ÀÖ´Ù. 

 

ClinicalTrials.gov: Federally-funded clinical studies related to COVID-19

WHO Trial Registry Network: COVID-19 studies from the ICTRP database

CDC: Information for Clinicians on Therapeutic Options for COVID-19 Patients

 


 

±¹°¡º° Áö¿ªº°·Î ÁøÇàÁßÀÎ ¿¬±¸¸¦ »ìÆ캸¸é ÀüüÀÇ ¹Ì±¹ÀÌ 34%¸¦ Â÷ÁöÇÏ°í ÀÖÀ¸¸ç ¹Ì±¹ ÀÌ¿Ü¿¡¼­ ¼öÇàµÇ´Â Àӻ󿬱¸´Â 49%·Î ¾Æ·¡ ±×¸²°ú °°´Ù.

 

 



 

¿¬µµº°·Î ClinicalTrials.gov¿¡ µî·ÏµÈ Àӻ󿬱¸ ÇöȲÀ» »ìÆ캸¸é ¾Æ·¡¿Í °°´Ù.

 

Source: http://clinicalTrials.gov




 

 

[¿ø¹®¹Ù·Î°¡±â]


 

 

 

      ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ Á¦°ø


 

 


2020-04-14 ¿ÀÈÄ 4:44:41, Á¶È¸¼ö : 3002